Key factors in reducing dementia risk
Dementia is often seen as an older person’s disease, but it’s important to understand that our lifestyle choices at any age can impact our risk.…
Category: Articles
Interventions for hearing loss lowers risk
A new study published in The Lancet Healthy Longevity journal suggests that wearing hearing aids can significantly lower the risk of mortality by 24%, according…
Everyday Meds That Can Worsen Alzheimer’s Symptoms
A recent article by Dr. Domenico Pratico, MD Director & Professor at Alzheimer’s Center at Temple University highlights prescription and OTC medications that may further…
Lowering Your Risk of Dementia and Stroke: Understanding Your Brain Care Score
Researchers at Massachusetts General Hospital have developed a new tool called the Brain Care Score (BCS) to help patients understand and reduce their risk of…
Healthy Brains Don’t Watch TV at Bedtime
A recent article by the Dementia Society of America sheds new light on the impact of staring at screens before bed. New research finds that…
A Spicy Memory Booster? Daily Wasabi May Enhance Memory in Seniors
A new study from Japan suggests that wasabi, the pungent green condiment served with sushi, could have powerful memory-enhancing effects. Researchers found that taking just…
Celebrities Shining a Light on Lesser Known Dementias
Creating awareness about dementias other than Alzheimer’sby Gary Skole While Alzheimer’s disease is the most common type of dementia, comprising up to 80% of cases,…
Tai Chi May Help Protect Against Cognitive Decline, According to New Study
A recent study published in Annals of Internal Medicine found that practicing tai chi may help slow age-related cognitive decline and protect against dementia. The…
Declining Deep Sleep in Seniors May Signal Higher Dementia Risk
A new study published in JAMA Neurology suggests that a decline in deep sleep may serve as an early warning sign for dementia risk. Researchers…
Encouraging results from a study on a subcutaneous formulation of Leqembi
Shortly after the FDA approved the much-anticipated Alzheimer’s drug Leqembi as an intravenous infusion, Eisai announced positive results from a study examining a subcutaneous formulation…